FDA says it seized counterfeit Ozempic
Newsy
Wholesalers, retail pharmacies, health care practitioners and patients are encouraged to check their product's lot and serial numbers.
The Food and Drug Administration has issued a new warning about counterfeit versions of the weight loss drug Ozempic.
The agency says it seized thousands of units of the counterfeit drug. However, the FDA believes there are still units in the U.S. drug supply chain.
Wholesalers, retail pharmacies, health care practitioners and patients are encouraged to check their product's lot and serial numbers. Products with lot number NAR0074 and serial number 430834149057 are counterfeit, the FDA.
Novo Nordisk, the manufacturer of Ozempic, and the FDA are reportedly testing the counterfeit product. There's concern that the drugs may not be effective and could pose safety concerns.
The FDA said it's already determined that the needles that accompany the counterfeit drugs are counterfeit, meaning their sterility cannot be confirmed. Use of a non-sterile needle can raise the risk of infection after the drug is administered.
